OpenAlex
PricingAboutJobs
Log inGet started
Work

Risk of hyperkalemia and combined use of spironolactone and long‐term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real‐life data: a population‐ and insurance‐based cohort

HTML

Year: 2015
Type: article
Study design: Observational Study
Source: Pharmacoepidemiology and Drug Safety
DOI: 10.1002/pds.3748
Authors: Sascha Abbas, Peter Ihle, Sebastian Harder, Ingrid Schubert
Institutions: University of Cologne, University Hospital Frankfurt
Language: English

Topic: Potassium and Related Disorders
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: hyperkalemia, spironolactone, ACE inhibitors, angiotensin receptor blockers, heart failure, mineralocorticoid receptor antagonists, drug-drug interactions, potassium monitoring, NYHA functional class, elderly patients, real-world evidence, adverse drug reactions, health insurance claims data, Germany, AOK, antihypertensive therapy, renin-angiotensin system
SDG: Good health and well-being

Open Access status: closed

Funders: Merck KGaA, Medicines Company
OpenAlex ID: W2123461279
FWCI: 3.924
Cites: 39
Cited by: 64
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security